Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
COVID-19
•
General Rheumatology
•
Inflammatory arthritis
What is your approach to management of inflammatory arthritis in the setting of multisystem inflammatory syndrome in adults (MIS-A) after COVID?
Related Questions
Do you regularly recommend an immunological workup for patients with suspected immunodeficiency or defer to immunology?
How do you counsel patients with depression about the role exercise may play in alleviating depressive symptoms?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Do you have to extend treatment for acute Lyme disease if a patient is on high dose steroids for another indication?
How do you weigh the risks and benefits of GLP-1 RAs in patients over age 65 specifically in regards to loss of muscle mass and osteoporosis?
How do you approach management of recurrent idiopathic pleuropericarditis?
Is there any benefit to checking serum viscosity in patients with autoimmune disease and headaches/migraines to see if aspirin or clopidogrel may be beneficial?
How do you approach laboratory evaluation in patients with fatigue?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
Do you have safety concerns when prescribing GLP-1 medications in patients on corticosteroids or immunosuppressive therapy?
